(Q45100334)

9 December 2017

title

Successful renal retransplantation after post-transplant lymphoproliferative disease (English)

1 reference

9 December 2017

Alexandre Karras

1

1 reference

9 December 2017

Eric Thervet

2

1 reference

9 December 2017

Yann Le Meur

3

1 reference

9 December 2017

Valérie Baudet-Bonneville

4

1 reference

9 December 2017

Michèle Kessler

5

1 reference

9 December 2017

Christophe Legendre

6

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

American Journal of Transplantation

9 December 2017

published in

1 reference

9 December 2017

volume

4

1 reference

9 December 2017

issue

11

1 reference

9 December 2017

page(s)

1904-1909

1 reference

Post-transplant lymphoproliferative disorder in the United States: young Caucasian males are at highest risk

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Long-term survival after post-transplant lymphoproliferative disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Early identification of Epstein-Barr virus-associated post-transplantation lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00562.X

10.1111/J.1600-6143.2004.00562.X

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference